Stilla Technologies Launches Access Program for Industry’s First Six-Color Digital PCR System New dPCR Platform Offers High Multiplexing and Sensitivity for Advancing Cancer & Liquid Biopsy Studies, Cell & Gene Therapies, Infectious Disease & COVID-19 Research, and Environmental Testing BOSTON and PARIS, July 28, 2021, – Stilla Technologies, the company innovating the next generation [...]
Stilla Technologies Strengthens Executive Team with Appointment of Matthew Grow, PhD, to Vice President Global Marketing and Commercial Operations Life Sciences Veteran to Lead Commercialization of Disruptive Digital PCR Technology for a Broad Range of Basic Research and Clinical Applications BOSTON and PARIS, June 30, 2021, – Stilla Technologies, the company innovating the [...]
June the 30th 2021 - (8 AM PDT | 11 AM EDT | 4 PM BST | 5 PM CEST), Liquid Biopsy Detection of EGFR Mutations in NSCLC Patients Before and After Osimertinib Therapy by Evi Lianidou (University of Athens) REGISTER HERE Speakers’s Bio Evi Lianidou, PhD Professor of Analytical Chemistry, Clinical [...]
March the 11th 2021 - (7 AM PDT | 10 AM EDT | 3 PM BST | 4 PM CEST), Advancing dPCR for various applications This webinar will cover how we are improving the ways we approach dPCR for various applications, and how we are addressing the challenges associated with the use of this [...]
Stilla expands leadership team to drive next phase of global commercial growth; appoints Philippe Mourere as President BOSTON, MA and PARIS, FRANCE - February 2, 2021 - Stilla Technologies is pleased to announce the appointment of Mr. Philippe Mourere as its new Chief Executive Officer. Former CEO and Founder Dr. Rémi Dangla has been [...]
February the 3rd 2021 - (8 AM PDT | 11 AM EDT | 4 PM BST | 5 PM CEST), Design and optimize high multiplexing digital PCR assays with the naica® system by Erik Wendlandt (Integrated DNA Technologies) & Kimberley Gutierrez (Stilla Technologies) Speakers’s Bio Erik Wendlandt Field Applications Scientist Integrated DNA Technologies [...]
Stilla Technologies launches its brand-new line of naica® PCR reagents and announces a partnership with ID-Solutions to commercialize the IDENTIFY kit line The naica® PCR mixes are specifically developed for optimized Crystal Digital PCR™ assays on the naica® system and the IDENTIFY kit line offers a range of full solutions for digital PCR applications [...]
October the 20th 2020 - (8 AM PDT | 11 AM EDT | 4 PM BST | 5 PM CEST), Crystal Digital PCR™ for Accurate Chimerism Monitoring after Stem Cell Transplantation by Elise Gourri (National Institute of Biology, Slovenia) & Viviane Sternkopf (Stilla Technologies) Speakers’s Bio Elise Gourri, MSc. Scientist Department of Molecular [...]
Stilla Technologies Launches the World’s First Six-Color Digital PCR Instrument Key Applications Include Oncology, Infectious Disease and Food Testing Paris, June 9th, 2020 Stilla Technologies, a leading provider of digital PCR (dPCR) solutions for high-precision genetic analysis, today launched the world’s first six-color digital PCR instrument, the six-color Prism. The instrument expands [...]
Stilla Technologies presents a novel approach for COVID-19 testing combining group testing with digital PCR and publishes the largest comparative study to date for group testing of SARS-CoV-2 The approach significantly reduces costs and increases testing capacity while offering a diagnostic sensitivity greater than the current standard of individual RT-PCR tests Paris, June 5th, [...]